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Patent Foramen Ovale
Going Beyond the Bubbles*William A. Zoghbi, MDHouston, TexasPatent foramen ovale (PFO) is not uncommondit
appears in perhaps 10% to 25% of the pop-
ulationdbut only a small percent of cases will
produce any clinical sequelae, such as refractory
hypoxia, orthodeoxia-platypnea syndrome, or
migraine headaches. PFO is most notorious, how-
ever, for its association with paradoxical embolus
and cryptogenic stroke (1). Conclusive proof of
a causal relationship between PFO and the clinical
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embolic presentation remains elusive, as it is rare
to visualize a paradoxical embolus in real time.
More perplexingly, trials aimed at closing PFOs
with various innovative devices have failed to
signiﬁcantly reduce clinical events, which indicates
that there may be a multitude of underlying patho-
genetic factors (2,3). Nevertheless, accurate and,
preferably, noninvasive diagnosis is needed to eval-
uate future stroke risk and help determine thera-
peutic decisions.
Diagnosing a PFO: Is There a Gold Standard?
PFO diagnosis has certainly evolved from the days
when a catheter had to cross the interatrial septum
(sometimes inadvertently) during heart catheteri-
zation. We can now detect a transient right-to-left
shunt (RLS) with contrast transthoracic echocar-
diography (TTE) or use transesophageal echocar-
diography (TEE) to visualize a PFO and the site*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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contents of this paper to disclose.of the shunt simultaneously. Transcranial Dopp-
ler (TCD) uses the same principle of ultra-
sound microbubble detection of an RLS by
demonstrating changes in Doppler signal from
the microbubbles in the middle cerebral artery
vessel(s). Each of these 3 ultrasound modalities has
advantages and limitations in the workup of a pa-
tient with stroke, but they should, in principle, be
equivalent: they all detect RLS by microbubbles,
either visually (TTE and TEE) or by Doppler shift
(TCD). Therefore, provided that the techniques
and visualization are adequate, and the physiology
behind the presence of the shunt (at rest or with a
provocative maneuver) is similar, there should be
no signiﬁcant difference in diagnostic accuracy.
Rarely, however, are these tests performed simul-
taneously for a true comparative accuracy of
detection of RLS.
In this issue of iJACC, however, Mojadidi et al.
(4) report on a bivariate meta-analysis of prospective
studies comparing PFO detection with TCD to the
standard of TEE. The investigators performed an
exhaustive search, identifying 27 reports with a total
of 1,968 patients. Agitated saline was used as the
contrast agent in the majority of studies (41%), and
the Valsalva maneuver was used as the sole provoc-
ative method in 86%, with cough in another 10%.
There was some variability among studies in the
deﬁnition of an RLS (from 1 to 15 bubbles by TCD
and from 1 to 20 bubbles by TEE). The sensitivity
of TCD for the diagnosis of intracardiac left-
to-right shunt was 97%, with speciﬁcity of 93%; as
expected, an increase in speciﬁcity was seen when
the number of bubbles detected by TCD was
increased from 1 to 10.
Although there may be small differences be-
tween the 2 techniques in detecting an RLS, they
are, for all intents and purposes, equivalent in
revealing PFO. The lower speciﬁcity seen with
Zoghbi J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 3 , 2 0 1 4
Editorial Comment M A R C H 2 0 1 4 : 2 5 1 – 3
252TCD could be related to the choice of the
standard for comparison, which raises the ques-
tion, what is the gold standard for diagnosing
a PFO?
The diagnosis of a PFO, from the perspective of
clinical signiﬁcance, requires both an anatomic and
a physiologic aspect. The physiologic assessment of
an RLS is usually performed using contrast TTE or
TCD before an anatomic conﬁrmation is demon-
strated, usually by TEE. This poses a challenge,
because for the shunt to occur, right atrial pressure
must exceed left atrial pressure at least transiently
(5,6). This may happen at rest but more often after
provocation with a Valsalva maneuver (with or
without cough). Because these provocation tech-
niques require physical effort, coordination, and
adequate timing, there is inevitable variability in the
results and detection of RLS. A previous study
documented that forced breathing into a tube with
monitoring of generated pressure produces higher
and more reliable pressure than that generated with
Valsalva and thus leads to higher RLS detection
rates (7). This would be relevant to the standard of
TEE in the present study, as patients are usually
sedated and instrumented with a transesophageal
probe, rendering the effort generated by a Valsalva
maneuver less than optimal compared with the
awake baseline state. Thus, although TEE is ex-
cellent in delineating the interatrial septum and
identifying a PFO anatomically, it may not be the
true gold standard for detecting RLS and is a source
of “false-negative” contrast studies. For this reason,
and provided that visualization of the chambers,
imaging window, and technique are adequate, TTE
with contrast injection at rest and upon repeated
Valsalva is a more robust standard for the detection
of an RLS than TEE. Because TCD is performed
in a setting similar to TTE, provocation maneuvers
are more reliable, and thus detection of RLS is more
robust. The accuracy of TCD is also, of course,
dependent on good technique, as artifacts can
simulate Doppler signals.
Only with a very small shunt (about 1 to 3
bubbles) is there possibly a difference in sensi-
tivity between echocardiographic and TCD
techniques: such few bubbles can be missed in a
tomographic echocardiographic plane and will be
more readily detected using a volumetric Doppler
approach (TCD). However, if the bubbles are
indeed very few, they may not go through the
middle cerebral artery from the left cardiac
chambers. Regardless, when dealing with such a
small shunt size, its clinical signiﬁcance starts to
become questionable.Toward Optimal Test Utilization
Recently, the clinical indications and practice
guidelines for TCD were published by the Amer-
ican Society of Neuroimaging, among which are
screening for RLS, determination of cerebral blood
ﬂow, and evaluation of embolic events during
surgery or interventions on the aorta or cerebral
vessels (8). Although TCD is a ﬁne, noninvasive
technique to determine whether an intracardiac
shunt is present, it is not particularly good for
differentiating an intracardiac shunt from a pul-
monary arteriovenous ﬁstula, and it does not pro-
vide the anatomy of the shunt or other possible
sources of embolism that may need to be investi-
gated (4). The older the patient, the higher the
likelihood of other potential cardiac sources of
emboli, such as left atrial or ventricular thrombi,
valvular disease, or disease of the thoracic aorta.
The question that arises then is, what are the next
steps after the TCD test? Do negative results
obviate the need for TTE or TEE? How about the
converse scenario: what is the next step after pos-
itive results on TCD? Should it be TEE or TTE
followed by TEE? There are no simple answers to
these questions, as the data have not been collec-
ted, but they are important to consider, as these
approaches would require patients to undergo several
tests (scheduling, inconvenience, intravenous lines,
and so on) with overlapping, redundant diagnostic
power and additional cost.
In short, in the evaluation of patients with
possible embolic stroke, the cardiac workup does not
stop with TCD, whether or not it reveals RLS. In
patients with RLS documented by either TTE or
TCD who have had clinical events, usually TEE is
subsequently performed, particularly when results
would alter management. These include veriﬁcation
that the underlying condition of the shunt is a
PFO (particularly if occlusion of the defect is
contemplated); assessment of other causes of RLS,
such as an atrial septal defect, fenestrations of the
interatrial septum, or a pulmonary arteriovenous
ﬁstula; documentation of a PFO (with or without
an interatrial septal aneurysm) in the case of a
technically difﬁcult transthoracic examination; and
evaluation of other potential sources of emboli (9).
Clinically, it is my experience that negative re-
sults on TCD for RLS do not dissuade clinicians
from ordering TTE (or TEE) to look for other
cardiac sources of emboli beyond a PFO, nor do
positive results on TCD preclude further evaluation
with echocardiography. Of interest is that the
relative value unit per the Centers for Medicare
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TTE with contrast and TCD, at 1.30, whereas that
for TEE is 2.65. Further studies are needed to
delineate the best approach to using these tech-
niques for optimal diagnosis and management of
patients with suspected cardiac emboli in a health-
care system in which both cost and patient out-
comes are important. Further research is also
needed to determine whether there are high-risk
groups that could be identiﬁeddon the basis ofthe magnitude of the shunt, the need for provoca-
tion, the size of the defect, and other clinical cri-
teriadand that would clearly beneﬁt from
interventions.
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